The Jianfeng Group and others have invested in establishing a cell biology technology company in Hainan.

According to the Qichacha APP, TianShiLi Cell Biotechnology Co., Ltd. was recently established with Ji Haibin as the legal representative and a registered capital of 10 million yuan. Its business scope includes medical services, technology import and export, goods import and export, cell technology research and application, and health consultation services, Among others. Qichacha's equity penetration shows that the company is fully owned by TianShiLi Biopharmaceutical Industry Group Co., Ltd., which is jointly held by TianShiLi Health Industry Investment Group Co., Ltd. and Apex Group.